Published in Diabet Med on March 01, 2006
Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ (2009) 2.69
Combined randomised controlled trial experience of malignancies in studies using insulin glargine. Diabetologia (2009) 2.34
Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence. Clin Med Res (2008) 1.17
Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care (2009) 0.98
Minimizing hypoglycemia while maintaining glycemic control in diabetes. Diabetes (2008) 0.94
Clinical experience with insulin glargine in type 1 diabetes. Diabetes Technol Ther (2010) 0.89
Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes? Diabetes Obes Metab (2015) 0.87
Enhanced modelling of the glucose–insulin system and its applications in insulin therapies. J Biol Dyn (2009) 0.84
Resource consumption and costs of treatment in patients with type 1 diabetes under intensified conventional therapy under German real-life conditions. J Diabetes Sci Technol (2013) 0.80
Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations. Diabetes Metab Syndr Obes (2012) 0.80
Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy. Obstet Gynecol Int (2012) 0.78
Long-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes. CADTH Technol Overv (2010) 0.76
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetologia (2008) 4.62
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med (1986) 3.90
Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. Br Med J (Clin Res Ed) (1982) 2.99
Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ (2001) 2.91
GATA3 haplo-insufficiency causes human HDR syndrome. Nature (2000) 2.73
Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med (1987) 2.30
Early closure of European Pimagedine trial. Steering Committee. Safety Committee. Lancet (1997) 2.28
Survey of diabetic retinopathy screening services in England and Wales. Diabet Med (1998) 2.22
Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med (1989) 2.21
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet (1994) 1.99
Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia (2009) 1.93
Protection by lactate of cerebral function during hypoglycaemia. Lancet (1994) 1.86
The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab (2003) 1.72
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
A computer-based chemical information system. Science (1977) 1.68
Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J (Clin Res Ed) (1982) 1.61
Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol (2000) 1.52
Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes (1992) 1.51
Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabet Med (1997) 1.50
Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax (1987) 1.48
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3). Diabetes Obes Metab (2015) 1.47
Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service. Diabet Med (2005) 1.46
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes. Diabetes Res Clin Pract (2011) 1.44
Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact? Diabet Med (2013) 1.42
Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care (1997) 1.42
The UK Diabetes Dataset: a standard for information exchange. Diabetes Audit Working Group of the Research Unit of the Royal College of Physicians. British Diabetic Association. Diabet Med (1995) 1.42
Time to stop talking about screening for diabetes? Diabet Med (2006) 1.42
Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis (2011) 1.40
Diabetes care in general practice: an approach to audit of process and outcome. Br J Gen Pract (1993) 1.40
Time to move from serum creatinine to eGFR. Diabet Med (2006) 1.39
Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled Type 1 diabetes. Diabetes Res Clin Pract (2010) 1.38
Diabetes and dementia: a causal association? Diabet Med (1994) 1.38
A fifteen-month double-blind cross-over study of the efficacy and antigenicity of human and pork insulins. Diabet Med (1984) 1.37
Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia (1987) 1.36
Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med (1993) 1.36
Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia (1991) 1.35
Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart. Diabet Med (2006) 1.33
Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. Br Med J (Clin Res Ed) (1981) 1.32
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) (1983) 1.31
Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states. Obes Rev (2007) 1.30
Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia (1993) 1.28
Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care (1997) 1.27
Regional differences in cerebral blood flow and glucose utilization in diabetic man: the effect of insulin. J Cereb Blood Flow Metab (1998) 1.26
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes (1987) 1.24
Correction of exercise-induced microalbuminuria in insulin-dependent diabetics after 3 weeks of subcutaneous insulin infusion. Diabetes (1981) 1.24
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet (1980) 1.24
Diagnostic confusion in diabetes with persistence of fetal haemoglobin. BMJ (1992) 1.20
Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients. Diabet Med (2002) 1.20
Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes. Diabetologia (2004) 1.20
Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog). Diabet Med (1998) 1.19
Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity. Clin Endocrinol (Oxf) (2009) 1.18
A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet (1998) 1.18
Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia (2005) 1.17
The role of complement in the induction of antibody responses. Clin Exp Immunol (1983) 1.16
The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet (2005) 1.15
Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia (2012) 1.14
Starting insulin treatment as an outpatient. Report of 100 consecutive patients followed up for at least one year. JAMA (1986) 1.14
Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ (1990) 1.14
Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabet Med (2010) 1.13
Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes (1993) 1.12
Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med (1988) 1.12
Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet (1987) 1.10
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study. Int J Clin Pract (2010) 1.10
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group. J Am Soc Nephrol (1999) 1.10
Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) (1988) 1.10
Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast. Br Med J (Clin Res Ed) (1983) 1.09
Comparison of thyroid function in pregnant and non-pregnant Asian and western Caucasian women. Clin Chim Acta (2001) 1.09
Hospital in-patient statistics underestimate the morbidity associated with diabetes mellitus. Diabet Med (1992) 1.09
Use of a patient linked data warehouse to facilitate diabetes trial recruitment from primary care. Prim Care Diabetes (2009) 1.08
A dataset to allow exchange of information for monitoring continuing diabetes care. The Diabetes Audit Working Group. Diabet Med (1993) 1.08
Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol (1988) 1.07
Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int (1982) 1.07
Response to Nandakoban et al. Acute tubulointerstitial nephritis following treatment with exenatide. Diabet Med (2013) 1.06
Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes. Diabet Med (2006) 1.05
Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int (1991) 1.05
Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care (2000) 1.04
Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract (2009) 1.04
Effects of adrenaline and potassium on QTc interval and QT dispersion in man. Eur J Clin Invest (2003) 1.04
Renal handling of calcium and sodium in metastatic and non-metastatic malignancy. Br Med J (Clin Res Ed) (1986) 1.04
Changes in regional brain (18)F-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure. Diabetes (2001) 1.03
Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes (2000) 1.03
Mathematical models for interacting groups in nuclear magnetic resonance titration curves. Biochemistry (1972) 1.03
Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes. Diabet Med (2014) 1.02
The epidemiology of hypothyroidism--an update. Baillieres Clin Endocrinol Metab (1988) 1.01
Asian women are at increased risk of gestational thyrotoxicosis. J Clin Endocrinol Metab (1996) 1.01
Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes. Diabetes Obes Metab (2012) 1.00
The effects of Bordetella pertussis vaccine on cerebral vascular permeability. Br J Exp Pathol (1976) 1.00
Diagnosing the undiagnosed with diabetes. BMJ (1994) 1.00
Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia (1994) 1.00